MacroGenics
MGNX
#8678
Rank
A$0.24 B
Marketcap
A$3.91
Share price
-6.51%
Change (1 day)
25.54%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): A-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.07169. In 2024 the company made an earnings per share (EPS) of A-$1.53 a decrease over its 2023 EPS that were of A-$0.22.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.20-87.09%
2024A-$1.53613.33%
2023A-$0.22-92.31%
2022A-$2.80-42.14%
2021A-$4.8336.44%
2020A-$3.54-21.84%
2019A-$4.53-24.58%
2018A-$6.01675.93%
2017A-$0.77-68.05%
2016A-$2.42168.25%
2015A-$0.90-55%
2014A-$2.013400%
2013A-$0.05736-108.68%
2012A$0.6624.49%
2011A$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.95-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.01-46,148.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.55-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.82-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.48-14,720.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.96-7,020.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$2.54 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA